Seychelles

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.25 (2.68 - 3.77) 2019 Modelled IHME
3.2 (2.76 - 3.62) 2018 Modelled IHME
3.18 (2.74 - 3.64) 2017 Modelled IHME
3.23 (2.75 - 3.67) 2016 Modelled IHME
3.29 (2.70 - 3.74) 2015 Modelled IHME
3.32 (2.73 - 3.77) 2014 Modelled IHME
3.35 (2.76 - 3.79) 2013 Modelled IHME
3.38 (2.83 - 3.81) 2012 Modelled IHME
3.4 (2.88 - 3.85) 2011 Modelled IHME
3.43 (2.91 - 3.91) 2010 Modelled IHME
3.46 (2.93 - 3.93) 2009 Modelled IHME
3.48 (2.95 - 3.99) 2008 Modelled IHME
3.51 (2.96 - 4.06) 2007 Modelled IHME
3.54 (2.98 - 4.13) 2006 Modelled IHME
3.57 (2.98 - 4.20) 2005 Modelled IHME
3.61 (3.03 - 4.21) 2004 Modelled IHME
3.67 (3.05 - 4.25) 2003 Modelled IHME
3.72 (3.10 - 4.30) 2002 Modelled IHME
3.78 (3.14 - 4.39) 2001 Modelled IHME
3.83 (3.18 - 4.44) 2000 Modelled IHME
3.86 (3.23 - 4.45) 1999 Modelled IHME
3.89 (3.28 - 4.50) 1998 Modelled IHME
3.92 (3.29 - 4.55) 1997 Modelled IHME
3.95 (3.31 - 4.60) 1996 Modelled IHME
3.99 (3.31 - 4.66) 1995 Modelled IHME
4.04 (3.36 - 4.71) 1994 Modelled IHME
4.09 (3.40 - 4.79) 1993 Modelled IHME
4.15 (3.44 - 4.88) 1992 Modelled IHME
4.22 (3.48 - 4.98) 1991 Modelled IHME
4.29 (3.52 - 5.08) 1990 Modelled IHME
0.43 (0.12 - 1.16) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.3 (0.21 - 0.40) 2019 Modelled IHME
0.31 (0.22 - 0.42) 2018 Modelled IHME
0.32 (0.23 - 0.44) 2017 Modelled IHME
0.34 (0.25 - 0.46) 2016 Modelled IHME
0.37 (0.26 - 0.50) 2015 Modelled IHME
0.43 (0.30 - 0.59) 2014 Modelled IHME
0.55 (0.38 - 0.74) 2013 Modelled IHME
0.68 (0.48 - 0.91) 2012 Modelled IHME
0.78 (0.55 - 1.04) 2011 Modelled IHME
0.82 (0.58 - 1.11) 2010 Modelled IHME
0.76 (0.54 - 1.03) 2009 Modelled IHME
0.62 (0.44 - 0.85) 2008 Modelled IHME
0.46 (0.33 - 0.62) 2007 Modelled IHME
0.32 (0.23 - 0.43) 2006 Modelled IHME
0.26 (0.19 - 0.35) 2005 Modelled IHME
0.27 (0.20 - 0.36) 2004 Modelled IHME
0.29 (0.21 - 0.38) 2003 Modelled IHME
0.31 (0.22 - 0.41) 2002 Modelled IHME
0.34 (0.24 - 0.45) 2001 Modelled IHME
0.36 (0.26 - 0.50) 2000 Modelled IHME
0.39 (0.28 - 0.53) 1999 Modelled IHME
0.42 (0.30 - 0.57) 1998 Modelled IHME
0.46 (0.33 - 0.61) 1997 Modelled IHME
0.51 (0.36 - 0.68) 1996 Modelled IHME
0.57 (0.41 - 0.78) 1995 Modelled IHME
0.72 (0.51 - 0.98) 1994 Modelled IHME
1 (0.71 - 1.34) 1993 Modelled IHME
1.38 (0.98 - 1.84) 1992 Modelled IHME
1.83 (1.31 - 2.44) 1991 Modelled IHME
2.32 (1.65 - 3.11) 1990 Modelled IHME
0.15 (0.04 - 0.44) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
3,133 (2,571 - 3,708) 1990 Modelled IHME
3,113 (2,570 - 3,672) 1991 Modelled IHME
3,097 (2,568 - 3,638) 1992 Modelled IHME
3,085 (2,566 - 3,611) 1993 Modelled IHME
3,076 (2,558 - 3,590) 1994 Modelled IHME
3,073 (2,552 - 3,586) 1995 Modelled IHME
3,076 (2,573 - 3,577) 1996 Modelled IHME
3,087 (2,587 - 3,585) 1997 Modelled IHME
3,102 (2,614 - 3,584) 1998 Modelled IHME
3,119 (2,608 - 3,599) 1999 Modelled IHME
3,134 (2,603 - 3,639) 2000 Modelled IHME
3,141 (2,608 - 3,648) 2001 Modelled IHME
3,139 (2,614 - 3,627) 2002 Modelled IHME
3,133 (2,604 - 3,636) 2003 Modelled IHME
3,129 (2,626 - 3,645) 2004 Modelled IHME
3,132 (2,615 - 3,683) 2005 Modelled IHME
3,143 (2,649 - 3,667) 2006 Modelled IHME
3,156 (2,667 - 3,650) 2007 Modelled IHME
3,170 (2,687 - 3,635) 2008 Modelled IHME
3,184 (2,701 - 3,626) 2009 Modelled IHME
3,198 (2,717 - 3,649) 2010 Modelled IHME
3,210 (2,715 - 3,628) 2011 Modelled IHME
3,223 (2,695 - 3,636) 2012 Modelled IHME
3,232 (2,667 - 3,652) 2013 Modelled IHME
3,239 (2,661 - 3,679) 2014 Modelled IHME
3,239 (2,658 - 3,688) 2015 Modelled IHME
3,210 (2,734 - 3,652) 2016 Modelled IHME
3,195 (2,750 - 3,659) 2017 Modelled IHME
3,237 (2,799 - 3,669) 2018 Modelled IHME
3,316 (2,733 - 3,849) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
11.1 (8.52 - 14.10) 2019 Modelled IHME
10.6 (8.17 - 13.40) 2018 Modelled IHME
10.3 (8 - 12.80) 2017 Modelled IHME
10 (7.90 - 12.50) 2016 Modelled IHME
9.84 (7.81 - 12.30) 2015 Modelled IHME
9.68 (7.69 - 12) 2014 Modelled IHME
9.58 (7.60 - 11.80) 2013 Modelled IHME
9.56 (7.65 - 11.70) 2012 Modelled IHME
9.51 (7.50 - 11.70) 2011 Modelled IHME
9.47 (7.51 - 11.70) 2010 Modelled IHME
9.52 (7.52 - 11.60) 2009 Modelled IHME
9.63 (7.63 - 11.80) 2008 Modelled IHME
9.73 (7.77 - 11.90) 2007 Modelled IHME
9.84 (7.89 - 12) 2006 Modelled IHME
10.1 (8.09 - 12.40) 2005 Modelled IHME
10.8 (8.74 - 13.20) 2004 Modelled IHME
12 (9.71 - 14.50) 2003 Modelled IHME
12.8 (10.40 - 15.30) 2002 Modelled IHME
13.4 (10.90 - 15.90) 2001 Modelled IHME
13.7 (11.20 - 16.30) 2000 Modelled IHME
13.9 (11.20 - 16.60) 1999 Modelled IHME
13.9 (11.30 - 16.60) 1998 Modelled IHME
13.8 (11.30 - 16.70) 1997 Modelled IHME
13.8 (11.10 - 16.60) 1996 Modelled IHME
13.6 (10.80 - 16.50) 1995 Modelled IHME
13.5 (10.70 - 16.40) 1994 Modelled IHME
13 (10.40 - 15.80) 1993 Modelled IHME
12.8 (10.30 - 15.60) 1992 Modelled IHME
12.7 (10.20 - 15.40) 1991 Modelled IHME
12.7 (10.20 - 15.40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
11 (9 - 14) 2019 Modelled IHME
11 (8 - 14) 2018 Modelled IHME
10 (8 - 13) 2017 Modelled IHME
10 (8 - 12) 2016 Modelled IHME
10 (8 - 12) 2015 Modelled IHME
9 (8 - 12) 2014 Modelled IHME
9 (7 - 11) 2013 Modelled IHME
9 (7 - 11) 2012 Modelled IHME
9 (7 - 11) 2011 Modelled IHME
9 (7 - 11) 2010 Modelled IHME
9 (7 - 11) 2009 Modelled IHME
9 (7 - 11) 2008 Modelled IHME
9 (7 - 11) 2007 Modelled IHME
9 (7 - 11) 2006 Modelled IHME
9 (7 - 11) 2005 Modelled IHME
9 (8 - 11) 2004 Modelled IHME
10 (8 - 12) 2003 Modelled IHME
11 (9 - 13) 2002 Modelled IHME
11 (9 - 13) 2001 Modelled IHME
11 (9 - 13) 2000 Modelled IHME
11 (9 - 13) 1999 Modelled IHME
11 (9 - 13) 1998 Modelled IHME
11 (9 - 13) 1997 Modelled IHME
11 (9 - 13) 1996 Modelled IHME
10 (8 - 13) 1995 Modelled IHME
10 (8 - 12) 1994 Modelled IHME
10 (8 - 12) 1993 Modelled IHME
10 (8 - 12) 1992 Modelled IHME
9 (8 - 11) 1991 Modelled IHME
9 (7 - 11) 1990 Modelled IHME
11 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
38 (29 - 48) 2019 Modelled IHME
38 (29 - 48) 2018 Modelled IHME
38 (29 - 48) 2017 Modelled IHME
38 (29 - 48) 2016 Modelled IHME
38 (30 - 48) 2015 Modelled IHME
38 (30 - 47) 2014 Modelled IHME
38 (30 - 47) 2013 Modelled IHME
38 (30 - 47) 2012 Modelled IHME
38 (30 - 47) 2011 Modelled IHME
38 (29 - 47) 2010 Modelled IHME
37 (29 - 47) 2009 Modelled IHME
37 (29 - 47) 2008 Modelled IHME
37 (29 - 47) 2007 Modelled IHME
37 (29 - 47) 2006 Modelled IHME
37 (29 - 47) 2005 Modelled IHME
38 (30 - 47) 2004 Modelled IHME
38 (30 - 48) 2003 Modelled IHME
39 (31 - 49) 2002 Modelled IHME
40 (31 - 50) 2001 Modelled IHME
40 (31 - 50) 2000 Modelled IHME
40 (31 - 50) 1999 Modelled IHME
40 (31 - 50) 1998 Modelled IHME
40 (31 - 50) 1997 Modelled IHME
40 (31 - 50) 1996 Modelled IHME
40 (31 - 50) 1995 Modelled IHME
40 (31 - 50) 1994 Modelled IHME
40 (31 - 50) 1993 Modelled IHME
40 (31 - 51) 1992 Modelled IHME
41 (31 - 51) 1991 Modelled IHME
41 (32 - 51) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
96 2001 Survey/reported WHO/UNICEF
98 2000 Survey/reported WHO/UNICEF
99 1999 Survey/reported WHO/UNICEF
97 1998 Survey/reported WHO/UNICEF
97 1997 Survey/reported WHO/UNICEF
98 1996 Survey/reported WHO/UNICEF
99 1995 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.44 (1.17 - 1.79) 2019 Modelled IHME
1.45 (1.18 - 1.78) 2018 Modelled IHME
1.45 (1.18 - 1.78) 2017 Modelled IHME
1.45 (1.19 - 1.77) 2016 Modelled IHME
1.44 (1.18 - 1.78) 2015 Modelled IHME
1.45 (1.18 - 1.77) 2014 Modelled IHME
1.46 (1.20 - 1.78) 2013 Modelled IHME
1.47 (1.20 - 1.79) 2012 Modelled IHME
1.48 (1.20 - 1.81) 2011 Modelled IHME
1.48 (1.20 - 1.81) 2010 Modelled IHME
1.48 (1.20 - 1.82) 2009 Modelled IHME
1.49 (1.21 - 1.81) 2008 Modelled IHME
1.49 (1.20 - 1.81) 2007 Modelled IHME
1.49 (1.20 - 1.82) 2006 Modelled IHME
1.49 (1.20 - 1.82) 2005 Modelled IHME
1.49 (1.21 - 1.83) 2004 Modelled IHME
1.49 (1.21 - 1.83) 2003 Modelled IHME
1.5 (1.21 - 1.84) 2002 Modelled IHME
1.5 (1.21 - 1.84) 2001 Modelled IHME
1.51 (1.21 - 1.84) 2000 Modelled IHME
1.51 (1.21 - 1.86) 1999 Modelled IHME
1.51 (1.22 - 1.85) 1998 Modelled IHME
1.51 (1.22 - 1.85) 1997 Modelled IHME
1.52 (1.22 - 1.86) 1996 Modelled IHME
1.52 (1.23 - 1.87) 1995 Modelled IHME
1.52 (1.23 - 1.87) 1994 Modelled IHME
1.53 (1.23 - 1.87) 1993 Modelled IHME
1.53 (1.24 - 1.88) 1992 Modelled IHME
1.54 (1.23 - 1.88) 1991 Modelled IHME
1.54 (1.22 - 1.89) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
42 (36.80 - 47.40) 2011 Survey/reported Bibi J et al, 2011
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
1,125 (893 - 1,378) 1990 Modelled IHME
1,133 (907 - 1,387) 1991 Modelled IHME
1,142 (923 - 1,400) 1992 Modelled IHME
1,151 (929 - 1,413) 1993 Modelled IHME
1,161 (940 - 1,426) 1994 Modelled IHME
1,171 (945 - 1,440) 1995 Modelled IHME
1,181 (950 - 1,450) 1996 Modelled IHME
1,193 (961 - 1,457) 1997 Modelled IHME
1,205 (971 - 1,472) 1998 Modelled IHME
1,219 (981 - 1,499) 1999 Modelled IHME
1,234 (993 - 1,511) 2000 Modelled IHME
1,249 (1,009 - 1,531) 2001 Modelled IHME
1,263 (1,022 - 1,549) 2002 Modelled IHME
1,276 (1,033 - 1,560) 2003 Modelled IHME
1,290 (1,044 - 1,584) 2004 Modelled IHME
1,305 (1,056 - 1,598) 2005 Modelled IHME
1,321 (1,068 - 1,616) 2006 Modelled IHME
1,337 (1,081 - 1,629) 2007 Modelled IHME
1,352 (1,100 - 1,649) 2008 Modelled IHME
1,368 (1,108 - 1,674) 2009 Modelled IHME
1,383 (1,117 - 1,691) 2010 Modelled IHME
1,394 (1,128 - 1,704) 2011 Modelled IHME
1,400 (1,141 - 1,707) 2012 Modelled IHME
1,404 (1,154 - 1,714) 2013 Modelled IHME
1,410 (1,155 - 1,725) 2014 Modelled IHME
1,420 (1,160 - 1,750) 2015 Modelled IHME
1,440 (1,182 - 1,763) 2016 Modelled IHME
1,460 (1,190 - 1,786) 2017 Modelled IHME
1,471 (1,198 - 1,802) 2018 Modelled IHME
1,476 (1,199 - 1,826) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
10.8 (8.24 - 14.30) 2019 Modelled IHME
10.9 (8.31 - 14.20) 2018 Modelled IHME
10.8 (8.26 - 14.10) 2017 Modelled IHME
10.6 (8.19 - 13.80) 2016 Modelled IHME
10.5 (8.13 - 13.50) 2015 Modelled IHME
10.3 (7.97 - 13.20) 2014 Modelled IHME
10.2 (7.88 - 12.90) 2013 Modelled IHME
10.1 (7.85 - 12.80) 2012 Modelled IHME
9.99 (7.87 - 12.60) 2011 Modelled IHME
9.91 (7.81 - 12.40) 2010 Modelled IHME
9.96 (7.86 - 12.50) 2009 Modelled IHME
10 (7.97 - 12.60) 2008 Modelled IHME
10.1 (7.95 - 12.60) 2007 Modelled IHME
10.1 (7.93 - 12.60) 2006 Modelled IHME
10.2 (8.01 - 12.80) 2005 Modelled IHME
10.2 (8.02 - 12.90) 2004 Modelled IHME
10.1 (7.86 - 12.60) 2003 Modelled IHME
9.57 (7.47 - 12.10) 2002 Modelled IHME
9.18 (7.15 - 11.50) 2001 Modelled IHME
9.05 (6.97 - 11.40) 2000 Modelled IHME
9.16 (7.06 - 11.70) 1999 Modelled IHME
9.17 (7.04 - 11.80) 1998 Modelled IHME
9.14 (7.09 - 11.70) 1997 Modelled IHME
9.1 (7.04 - 11.60) 1996 Modelled IHME
8.93 (6.93 - 11.50) 1995 Modelled IHME
8.82 (6.83 - 11.50) 1994 Modelled IHME
8.47 (6.62 - 10.90) 1993 Modelled IHME
8.3 (6.47 - 10.60) 1992 Modelled IHME
8.14 (6.37 - 10.40) 1991 Modelled IHME
8.06 (6.33 - 10.30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
11 (8 - 15) 2019 Modelled IHME
11 (8 - 14) 2018 Modelled IHME
11 (8 - 14) 2017 Modelled IHME
11 (8 - 14) 2016 Modelled IHME
10 (8 - 13) 2015 Modelled IHME
10 (8 - 13) 2014 Modelled IHME
10 (8 - 12) 2013 Modelled IHME
10 (7 - 12) 2012 Modelled IHME
9 (7 - 12) 2011 Modelled IHME
9 (7 - 12) 2010 Modelled IHME
9 (7 - 11) 2009 Modelled IHME
9 (7 - 11) 2008 Modelled IHME
9 (7 - 11) 2007 Modelled IHME
9 (7 - 11) 2006 Modelled IHME
9 (7 - 11) 2005 Modelled IHME
9 (7 - 11) 2004 Modelled IHME
9 (7 - 11) 2003 Modelled IHME
8 (6 - 10) 2002 Modelled IHME
8 (6 - 10) 2001 Modelled IHME
7 (6 - 9) 2000 Modelled IHME
7 (6 - 9) 1999 Modelled IHME
7 (6 - 9) 1998 Modelled IHME
7 (6 - 9) 1997 Modelled IHME
7 (5 - 9) 1996 Modelled IHME
7 (5 - 9) 1995 Modelled IHME
7 (5 - 9) 1994 Modelled IHME
6 (5 - 8) 1993 Modelled IHME
6 (5 - 8) 1992 Modelled IHME
6 (5 - 8) 1991 Modelled IHME
6 (5 - 8) 1990 Modelled IHME
1 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
23 (16 - 31) 2019 Modelled IHME
24 (16 - 31) 2018 Modelled IHME
24 (17 - 32) 2017 Modelled IHME
24 (17 - 31) 2016 Modelled IHME
24 (17 - 31) 2015 Modelled IHME
24 (17 - 32) 2014 Modelled IHME
24 (17 - 32) 2013 Modelled IHME
24 (17 - 32) 2012 Modelled IHME
24 (17 - 32) 2011 Modelled IHME
25 (18 - 32) 2010 Modelled IHME
25 (18 - 32) 2009 Modelled IHME
25 (18 - 32) 2008 Modelled IHME
25 (18 - 32) 2007 Modelled IHME
25 (18 - 32) 2006 Modelled IHME
25 (18 - 33) 2005 Modelled IHME
25 (18 - 33) 2004 Modelled IHME
25 (18 - 32) 2003 Modelled IHME
25 (18 - 32) 2002 Modelled IHME
25 (18 - 32) 2001 Modelled IHME
25 (18 - 32) 2000 Modelled IHME
25 (18 - 33) 1999 Modelled IHME
25 (18 - 33) 1998 Modelled IHME
25 (18 - 33) 1997 Modelled IHME
25 (18 - 33) 1996 Modelled IHME
26 (18 - 33) 1995 Modelled IHME
26 (18 - 33) 1994 Modelled IHME
26 (19 - 34) 1993 Modelled IHME
26 (18 - 34) 1992 Modelled IHME
26 (18 - 34) 1991 Modelled IHME
26 (18 - 34) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
11
2019
(9 - 14)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
11
2019
(8 - 15)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines